Search Results for "biomarker"
“Potential biomarker that could predict”? – caveats about psychiatric brain imaging & blogging about it
The following is a guest blog post by Susan Molchan, MD. Dr. Molchan is a psychiatrist in practice in Bethesda, Maryland. She also trained in nuclear medicine and did PET research at the National Institute of Mental Health, and worked as the program director for Biomarkers, Diagnosis, and Alzheimer’s Disease at the National Institute on […]
Headline vs. study: Predicting, preventing and other clickbait
Predicting and preventing. These are powerful words that hold strong appeal for most of us, especially when it comes to our health. But the reality is this: There are very few diseases that can be predicted and prevented. Try to name just one and you’ll see that it’s rarely, if ever, possible. And yet we […]
Headline vs. Study: Using cancer as clickbait
Using cancer as clickbait is ubiquitous and worrisome. It’s one thing to highlight studies that represent genuine progress, and quite another to write hopeful headlines about studies that are clearly not ready for prime time. Such is the case with 4 of the stories we feature below. It may seem like too widespread a problem […]
What you need to know about yet another study on Alzheimer’s and exercise
Including “exercise” and “Alzheimer’s” in the same headline is sure-fire clickbait for a lot of people. For example: 150 minutes of exercise every week can reduce risk of Alzheimer’s disease (The Economic Times) Exercise may delay rare form of Alzheimer’s (HealthDay) But these headlines refer to a study published earlier this week that doesn’t justify such […]4 7/30/2018
Problematic PR releases: Where’s the data?
We’ve been closely tracking healthcare-related news releases for several years now, systematically reviewing more than 550 using our 10 criteria. We can’t get to every news release we see–the churn is vast. That’s why we’re starting a new ongoing blog series, problematic PR releases, looking at some of the big-picture problems we see in news […]
Questions about a ‘simple blood test’ to screen for cancer prompt revealing answer: It’s complicated
We often tell our readers to run for the hills whenever they see a news story touting a “simple blood test.” You won’t find a better example of why you need to be wary than an exchange between a reporter and a researcher at a news conference at the American Society of Clinical Oncology’s annual […]
‘$7.9 trillion’ savings from earlier Alzheimer’s diagnosis: Is there a hidden agenda behind the numbers?
More disease advocacy organizations are enlisting business consulting groups to conduct research to further their causes and, not coincidentally, those of their pharmaceutical company sponsors. This week the strategy paid off for the Alzheimer’s Association: An article in Bloomberg News headlined “Spotting Alzheimer’s Early Could Save America $7.9 Trillion” came from the annual Facts and […]1
Lowering the bar on Alzheimer’s drugs: STAT op-ed takes industry-friendly line, without disclosing author’s pharma ties
A recent op-ed published Monday in STAT insists that proposed FDA guidance for Alzheimer’s drug development is “good news” that “removes unnecessary barriers” to bring new medications to market. If the guidance is finalized, pharmaceutical companies would no longer have to prove that their drugs impact the endpoints of “cognition and function” when tested on […]1
Up-and-down coverage of standing desks leaves readers in limbo
Did you know you can get whiplash without even leaving your desk? Just read the headlines about the health effects of standing while you work. For a few years now we’ve been hearing claims about the health benefits of standing at your desk, while being warned that sitting too long can kill you. This week a […]
Headline vs. study: The unbearable heaviness of false hope
Here’s a perfect storm. Take several common diseases that affect millions of people — like antibiotic-resistant infections, Alzheimer’s disease, major depression and bipolar disease — and then write headlines about recent (or old!) studies on these illnesses that hint at hope. But then, in the ensuing article, don’t give your readers evidence to support your […]1
More evidence that women should be wary of ‘ovarian reserve testing’ events
A number of major news outlets reported on a new study in JAMA that determined ovarian reserve tests aren’t a good predictor of fertility among women trying to conceive naturally who have no history of infertility. Common biomarker tests to assess ovarian reserve–including antimüllerian hormone (AMH) and follicle-stimulating hormone (FSH)–are often given to women to assess their reproductive […]
Headline vs. study: Stem cells ‘slow aging’ and ‘rejuvenate’ old hearts
A 2014 analysis by the Media Insight Project found that about 6 out of 10 Americans admit they did nothing more than scan the headlines in the past week. And that’s just the people that admit it. Then, last summer, French and American researchers found that nearly 60 percent of links shared on social media had never been clicked […]6
Facts about the new ALS drug Radicava that you’re unlikely to see in news stories
Talking to me with the assistance of a speaking valve, Chris Simon made it clear what he thought of Radicava, a newly approved drug for patients who have amyotrophic lateral sclerosis (ALS). “It’s more fool’s gold than it is gold,” said Simon, who has ALS and lives in California. He doesn’t plan to take the […]3
5 questions to ask when writing (and reading) about new Alzheimer’s drug research
Now is a good time to prepare for the onslaught of public relations messages about new Alzheimer’s disease (AD) drugs that are coming down the pike. This fall, at least six phase III AD drug trials will be wrapping up–and it’s a sure bet their findings will be published in both major and minor journals […]4
Experts recommend pulling widely used heart attack test: Should this have made headlines?
For decades the creatine kinase-myocardial band test, or CK-MB for short, was the go-to blood test doctors used to determine if a patient’s heart muscle had been damaged by a heart attack (or, myocardial infarction). But over the past few years the reliability of the test has been called into question by several major, peer-reviewed […]